Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis Lung Carcinoma cells
- 1 June 1983
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 32 (11) , 1689-1691
- https://doi.org/10.1016/0006-2952(83)90110-7
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Tumor Shedding and CoagulationScience, 1981
- Procoagulant activity of sarcoma sublines with different metastatic potentialBlood, 1981
- In vitro effects on tumor cells of macrophages isolated from an early‐passage chemically‐induced murine sarcoma and from its spontaneous metastasesInternational Journal of Cancer, 1981
- Cancer cell procoagulant activity: Evaluation by an amidolytic assayThrombosis Research, 1980
- MALIGNANCY AND HAEMOSTASISBritish Journal of Haematology, 1980
- Evidence that cells from experimental tumours can activate coagulation factor XBritish Journal of Cancer, 1979
- Growth and metastasis of the Lewis lung carcinoma in mice defibrinated with batroxobinPublished by Elsevier ,1978
- WARFARIN ENANTIOMERS, ANTICOAGULATION, AND EXPERIMENTAL TUMOUR METASTASISThe Lancet, 1978
- Fibrinogen metabolism in experimental tumoursPublished by Elsevier ,1969
- Coagulative properties of cancersIrish Journal of Medical Science, 1958